New drug for asthma and eczema passes first safety check in healthy people
NCT ID NCT05803902
First seen Jan 05, 2026 · Last updated May 21, 2026 · Updated 28 times
Summary
This early-stage study tested a new medicine called 9MW1911 in 48 healthy adults to see if it is safe and how the body processes it. The goal was to find the right dose and check for side effects, not to treat any disease. Results will help guide future studies in people with asthma, COPD, or atopic dermatitis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking Union Hospital
Beijing, Beijing Municipality, 100000, China
Conditions
Explore the condition pages connected to this study.